Thanhtruc Hoang Phan, FNP-C

Thanhtruc Phan practices at Sharp Rees-Stealy Medical Group, Inc in San Diego, California.

Thanhtruc Phan's NPI, 1578928321, was assigned on December 22, 2015. Thanhtruc Phan holds California license 95003338.

Thanhtruc Phan's primary practice is Sharp Rees-Stealy Medical Group, Inc, at 5651 Copley Dr, San Diego, CA 92111 in San Diego County. The practice phone is (858) 262-6666.

Thanhtruc Phan's primary practice is Sharp Rees-Stealy Medical Group, Inc in San Diego, California. The medical group on file is Sharp Rees-Stealy Medical Group. Dmand AI also links Thanhtruc Phan to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Thanhtruc Phan practices. Vendor and product names are available with a free account.

Family is Thanhtruc Phan's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Thanhtruc Phan is licensed in California.

Dmand AI lists acute sinusitis, acute skin infection, benign or precancerous skin growths, contact dermatitis, ear infection, hand joint or tendon inflammation, joint pain and lower back pain among the conditions Thanhtruc Phan treats.

CMS data shows 95 Medicare services from Thanhtruc Phan across 2 procedure codes in 2024, all of them office visits, for 101 Medicare patients. Medicare paid $4,907 for them. Every service was in an office.

CMS counts 101 Medicare patients who saw Thanhtruc Phan in 2024. The largest group is 65 to 74, with 56 patients. 59% of them have high blood pressure, and 53% have high cholesterol. 19% are also on Medicaid. Their average risk score is 0.99, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Thanhtruc Phan's median patient age at 53, with 73% women.

In 2024, Thanhtruc Phan wrote 1,074 Medicare Part D claims for 794 patients. 92% of them were for generic drugs. CMS names the drug for 632 of them, across 28 drugs with 11 or more claims each, at $7,128 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Thanhtruc Phan for performance year 2024, reported as part of a group. Thanhtruc Phan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Thanhtruc Phan as offering telehealth.

CMS Open Payments shows 1 general payment to Thanhtruc Phan from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Axsome Therapeutics, Inc. paid the most, $125.